质子泵抑制剂对PCI术后双联抗血小板治疗所致上消化道出血的影响

乔雁翔, 陈巍, 卢星文, 谢昌明

乔雁翔, 陈巍, 卢星文, 谢昌明. 质子泵抑制剂对PCI术后双联抗血小板治疗所致上消化道出血的影响[J]. 实用临床医药杂志, 2013, (16): 9-11. DOI: 10.7619/jcmp.201316004
引用本文: 乔雁翔, 陈巍, 卢星文, 谢昌明. 质子泵抑制剂对PCI术后双联抗血小板治疗所致上消化道出血的影响[J]. 实用临床医药杂志, 2013, (16): 9-11. DOI: 10.7619/jcmp.201316004
QIAO Yanxiang, CHEN Wei, LU Xingwen, XIE Changming. Influence of proton pump inhibitors on upper gastrointestinal bleeding induced by dual antiplatelet therapy after PCI[J]. Journal of Clinical Medicine in Practice, 2013, (16): 9-11. DOI: 10.7619/jcmp.201316004
Citation: QIAO Yanxiang, CHEN Wei, LU Xingwen, XIE Changming. Influence of proton pump inhibitors on upper gastrointestinal bleeding induced by dual antiplatelet therapy after PCI[J]. Journal of Clinical Medicine in Practice, 2013, (16): 9-11. DOI: 10.7619/jcmp.201316004

质子泵抑制剂对PCI术后双联抗血小板治疗所致上消化道出血的影响

详细信息
  • 中图分类号: R573.2

Influence of proton pump inhibitors on upper gastrointestinal bleeding induced by dual antiplatelet therapy after PCI

  • 摘要: 目的 探讨质子泵抑制剂对PCI术后双联抗血小板治疗所致上消化道出血的影响.方法 选择冠状动脉粥样硬化性心脏病并接受PCI治疗的患者218例,随机分为观察组与对照组.观察组在阿司匹林+氯吡格雷抗血小板治疗的基础上联合口服埃索美拉唑治疗,比较2组患者血小板聚集率、上消化道出血和支架内血栓形成的发生率.结果 2组患者PCI术前及术后12周比较血小板聚集率均无显著差异(P>0.05);术后随访12月,观察组无上消化道出血发生,对照组发生率为3.67%,差异有统计学意义(P<0.05);观察组支架内血栓形成2例(1.83%),对照组1例(0.91%),差异无统计学意义(P>0.05).结论 埃索美拉唑可预防患者PCI术后双联抗血小板治疗所致上消化道出血等并发症的发生,且并未影响抗血小板活性,也未增加支架内血栓形成的概率.
  • 张振香, 郑蔚, 李俊玲. 经皮冠脉介入治疗术后上消化道出血的危险因素 [J]. 中国老年学杂志, 2008, (24):2455.doi: 10.3969/j.issn.1005-9202.2008.24.026.
    Bertrand M E, Simoons M L, Fox K A. Management of acute coronary syndromes:acute coronary syndromes without persistent ST segment elevation:recommendation of the task force of the European society of cardiology [J]. European Heart Journal, 2000, (17):1406.
    Leong LC, Sim LS, Lee YS. A prospective study to compare the diagnostic performance of breast elastography versus conventional breast ultrasound [J]. Clinical Radiology, 2010, (11):887.
    Bhatt D L, Scheiman J, Abraham N S. ACCF/ACG /AHA 2008 expert consensus document on reducing the gastrointestinal risk s of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Fotmdation Task Force on Clinical Expert Consensus Documents [J]. Circulation, 2008, (18):1894.
    霍勇, 刘兆平. 抗凝与抗血小板药物在急性冠状动脉综合征的应用 [J]. 中国实用内科杂志, 2008(1):18.doi: 10.3969/j.issn.1005-2194.2008.01.009.
    黄伟杰, 肖文星. PCI术后上消化道出血的研究进展 [J]. 实用心脑肺血管病杂志, 2012(7):1253.doi: 10.3969/j.issn.1008-5971.2012.07.106.
    陶杰, 韩雅玲, 王效增. PCI围术期消化道出血患者抗血小板治疗调整及近期疗效 [J]. 现代生物医学进展, 2010, (24):4690.
    NgFH, Wong SY, Lam K F. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome [J]. American Journal of Gastroenterology, 2008(4):865.
    Pezalla E, Day D, Pulliadath I. Initial assessment of clinical impact of a drug interaction between clopidngrel and proton pump inhibitors [J]. Journal of the American College of Cardiology, 2008, (12):1038.
    Juurlink D N, Gomes T, Ko D T. A populationbased study of the drug interaction between proton pump inhibitors and clopidogrel [J]. Canadian Medical Association Journal, 2009(7):713.
计量
  • 文章访问数:  245
  • HTML全文浏览量:  24
  • PDF下载量:  8
  • 被引次数: 0
出版历程
  • 发布日期:  2013-10-14

目录

    /

    返回文章
    返回